The prevalence of depression amongst outpatients with multimorbidity by Stanners, M. et al.
PUBLISHED VERSION  
http://hdl.handle.net/2440/80762  
 
Melinda Stanners, Christopher Barton, Sepehr Shakib, Helen Winefield 
The prevalence of depression amongst outpatients with multimorbidity 
Health (Irvine), 2013; 5(4):805-810 
Copyright © 2013 Melinda Stanners et al. This is an open access article distributed under the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any 
medium, provided the original work is properly cited. 





























Vol.5, No.4, 805-810 (2013)                                                                           Health 
http://dx.doi.org/10.4236/health.2013.54106  
The prevalence of depression amongst outpatients 
with multimorbidity 
Melinda Stanners1*, Christopher Barton1, Sepehr Shakib2, Helen Winefield3 
 
1Social Health Science, Flinders University, Adelaide, Australia; *Corresponding Author: melinda.stanners@flinders.edu.au  
2Clinical Pharmacology, Royal Adelaide Hospital, Adelaide, Australia 
3Discipline of Psychiatry, University of Adelaide, Adelaide, Australia 
 
Received 24 February 2013; revised 26 March 2013; accepted 10 April 2013 
 
Copyright © 2013 Melinda Stanners et al. This is an open access article distributed under the Creative Commons Attribution License, 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
ABSTRACT 
Objectives: Depression may be under-diag- 
nosed and under-treated amongst older adults 
with multiple chronic illnesses. The current 
study explores the prevalence of depression 
diagnosis and Geriatric Depression Scale (GDS) 
symptoms amongst older multimorbid outpa- 
tients, and agreement between GDS scores and 
doctor-diagnosed depression. Method: Deiden- 
tified data from the files of 452 patients aged 
over 64, with chronic conditions present in two 
or more organ domains, were extracted from the 
clinical database of a tertiary referral hospital 
multidisciplinary outpatient clinic in South Aus- 
tralia between 2005 and 2011. Frequency calcu- 
lations determined the prevalence of depression 
diagnosis and GDS categories. Logistic regres- 
sion, cross-tabulation, kappa and ROC graphs 
explored relationships between variables. Re- 
sults: A depression diagnosis had been re- 
corded for 71 (15.7%) patients. Using the recom- 
mended cut-off scores for the GDS, 225 (49.8%) 
patients met criteria for mild-severe depressive 
symptoms, and 96 (21.3%) met criteria for mod- 
erate-severe symptoms. Poor agreement was 
found between doctor diagnosis of depression 
and a positive screen for depression using a 
GDS cut-off score of either 5, k = 0.112 (p = 
0.001), or 9, k = 0.189 (p < 0.001), although logis- 
tic regression found an association between 
severity of depression and depression diagno- 
sis, OR = 1.15, p < 0.001 (CI = 1.08 - 1.22). Con- 
clusion: A much higher proportion of patients 
with multimorbidities reported threshold level 
depression symptoms than had a recorded di- 
agnosis of depression, suggesting that although 
likelihood of diagnosis increases with symptom  
severity, depression often goes undetected in 
this population. Depressions’ negative impact 
on prognosis calls for further investigation of 
the barriers to screening and diagnosis of de- 
pression in multimorbid patients. 
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1. INTRODUCTION 
More people are living with chronic illnesses for 
longer, and the likelihood of developing one or more 
chronic illnesses increases with age [1]. The relationship 
between mental health and multiplicity of disease is im- 
portant as the risk of developing depression increases 
where two or more chronic conditions are present [2]. 
When patients present to their clinician with multiple 
chronic conditions, or “multimorbidity”, the treatment of 
physical symptoms may take precedence over psycho- 
logical symptoms [3], creating challenges in the detec- 
tion and management of depression. Additionally, com- 
plex symptom profiles create challenges in detecting de- 
pression, as physical symptoms such as low energy, poor 
appetite, weight loss or cognitive decline may be related 
to depression, or disease, or both [4]. Social symptoms of 
depression may also be attributed to physical illness [5], 
leaving clinicians struggling to differentiate between so- 
cial and psychological issues amongst older adults [6,7]. 
Reliance on patient reports of psychological symptoms, 
particularly amongst older patients, may be compromised 
by stigma related to depression [8]. Consequently it is 
unsurprising that depression is thought to be under-di- 
agnosed and under-treated amongst older people in West- 
ern nations [9-11]. 
A range of scales have been developed to assist with 
the diagnostic process, but previous research suggests  
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that overlap of physical and psychological symptoms 
may render diagnostic tools that rely on somatic symp- 
toms unreliable [12,13]. One tool often used in aged 
populations is the 15-question Geriatric Depression Scale 
(GDS) developed at Stanford University [14] to screen 
for symptoms of depression in aged individuals, which 
has been validated in aged community-dwelling popula- 
tions [15-17]. A GDS score of 5 has been found to have a 
sensitivity of 91% and a specificity of 72% for depres- 
sion [18], but neither the scale nor the categorisation 
scores have been validated in patients with multiple 
chronic conditions. In light of the challenges of depres- 
sion diagnosis, exploring the performance of the GDS in 
multimorbid patients would make a valuable contribution 
to clinicians concerned about detecting depression in this 
population. 
Whilst multimorbidity is most often defined as two or 
more chronic conditions [19], disease count does not 
accurately reflect disease burden [20]; consequently this 
definition may be less appropriate for use for mental 
health research. As age-related increases in depression 
may be attributable to declines in physical health, physi- 
cal function and perceptions of well-being [21], Fortin et 
al.’s 2005 definition of multimorbidity as the presence of 
disease in two or more organ domains may be more ap- 
propriate for exploring the relationship between multi- 
morbidity and mental health, and consequently has been 
applied in the current study. 
We aimed to explore the prevalence of depression di- 
agnoses and symptoms in multimorbid community-dwell- 
ing outpatients, hypothesising equivalent rates of depres-
sion diagnosis and threshold-level depression symptoms 
as measured by the GDS. We anticipated good agreement 
between doctor-diagnosed depression and GDS scores. 
2. METHOD 
De-identified data were extracted from the clinic da- 
tabase for 452 patients with multiple chronic conditions 
referred to a metropolitan multidisciplinary clinic be- 
tween September 2005 and September 2011. The Mul- 
tidisciplinary Ambulatory Consulting Service (MACS) 
clinic provides integrated multidisciplinary care for mul- 
timorbid outpatients. Patients complete an extensive self- 
report health and lifestyle questionnaire, which includes 
the 15 question Geriatric Depression Scale (GDS), and 
the responses are entered into the clinic database. Medi- 
cations, vitamins and supplements are recorded in the 
database, as well as chronic conditions and acute health 
events. Depression diagnoses are recorded in the data- 
base if the diagnosis is included in the referral letter from 
the general practitioner. The current or remitted state of 
depression is not recorded in the database; nor is whether 
the diagnosis was given by a general practitioner or psy- 
chiatrist. 
Chronic conditions were grouped into Cumulative Ill- 
ness Rating Scale (CIRS) domains [20], with disease 
present in cardiac, vascular, endocrine, respiratory, renal, 
neurological, musculo-skeletal, psychiatric and upper GI 
domains (see Table 1). The psychiatric domain was ex- 
cluded due to high co-linearity with depression diagnosis. 
Patients with chronic conditions in two or more domains 
(not including the psychiatric domain) and a recorded 
GDS score in their file were included in the data set, but 
excluded if they had a diagnosis of dementia or if they 
were less than 65 years of age. 
Data were analysed using PASW Statistics Version 18. 
To estimate the prevalence of depressive symptoms, fre- 
quency calculations demonstrated the proportion of pa- 
tients with a GDS score of greater than or equal to 5 (mild- 
severe depression) and 9 (moderate-severe depression) 
respectively [14]. Frequency calculations were also used 
to explore demographic data and the prevalence of de- 
pression diagnoses. Logistic regression was used to ex-
plore association of GDS score severity with depression 
diagnosis. Cross-tabulation, kappa calculations and ROC 
graph analysis were then applied to explore the agree- 
ment between depression diagnosis and GDS categorisa-
tion. 
Ethics approval for this study was granted by the Ro- 
yal Adelaide Hospital Ethics Committee. MS was sup- 
ported by a scholarship from the Faculty of Health Sci-
ence at the University of Adelaide and a supplementary 
scholarship from the Clinical Pharmacology unit at the 
Royal Adelaide Hospital. The authors had full access to 
all data in the study. 
3. RESULTS 
Demographic data for the 452 eligible patients are de- 
scribed in Table 2. Depression diagnoses were recorded 
for 15.7% of patients, with women overrepresented in 
this group. When the standard GDS scoring categories 
 
Table 1. Disease domains and conditions. 
Domain Conditions 
Cardiac Atrial fibrillation, heart failure, ischemic heart disease 
Vascular Pulmonary vascular disease, thrombosis, lipids,hypertension 
Endocrine Diabetes 
Musculo-skeletal Osteoarthritis, osteoporosis, gout, arthritis 
Renal Chronic renal failure 
Respiratory Asthma, chronic obstructive pulmonary disease,sleep apnea 
Upper GI Gastro-oesophageal reflux disease 
Neurological Parkinson’s disease, epilepsy, cardiovascular disease 
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Table 2. Frequency table of demographic, antidepressant, depression and GDS variables (N = 452). 
Age  Range = 65 - 98 years Mean = 79.7 (SD = 7.06) 
Disease Domain Count Range = 2 - 8 Median = 4 (SE = 0.06) 
Male 202 (44.7%) 
Gender 
Female 250 (55.3%) 
Partner Only 192 (42.5%) 
Alone 138 (30.5%) 
With Carer 14 (3.1%) 
Other/Unknown 61 (13.5%) 
Living Circumstance 
Other Family Present 47 (10.4%) 
Non-Smoker 206 (45.6%) 
Ex-Smoker 213 (47.1%) Tobacco Use 
Smoker 28 (6.2%) 
Male  32 (16.2%) 
Female 75 (31.4%) 
SSRI 59 (62.8%) 
Tricyclic 35 (37.2%) 
History of Depression  50 (46.7%) 
Antidepressant Use N = 107 (23.7%) 
No History of Depression  57 (53.3%) 
Male 25 (12.4%) 
Clinical Depression History N = 71 (15.7%) 
Female 46 (18.4%) 
No Depression  227 (50.2%) 
Mild Depression  129 (28.5%) 
Moderate Depression  56 (12.4%) 
GDS Category 
Severe Depression  40 (8.9%) 
 
were applied, approximately half of all patients (49.8%) 
scored five or more on the GDS, with 21.2% scoring in 
the moderate-severe range (9 - 15) for depressive symp- 
toms (Table 2). 
One hundred and seven (23.7%) patients had been pre- 
scribed an antidepressant at the time of their first clinic 
visit, more than half of whom had no diagnosis of de- 
pression (Table 2). Women were twice as likely as men 
to be taking an antidepressant on their first visit to the 
clinic (Table 2). Antidepressant status data were missing 
for 16 patients. 
Table 3 describes the GDS categorisations for patients 
with and without depression who did and did not have an 
antidepressant at their first visit to the clinic. Of the 71 
patients with a diagnosis of depression, 50 (72.5%) were 
taking an antidepressant. Of the 169 people with no di- 
agnosis of depression and sub-threshold GDS symptoms, 
26 (13.1%) were taking an antidepressant upon entry to 
the clinic. Amongst patients with neither a diagnosis of 
depression nor an antidepressant prescription, however, 
51 (16.4%) scored in the moderate-severe range of the 
GDS. 
Detailed antidepressant data were available for only 94 
patients, with 59 taking selective serotonin reuptake in- 
hibitors (SSRIs) and 35 taking tricyclics antidepressants 
(TCAs). Comparing antidepressant type between the pre- 
sence or absence of a diagnosis of depression or anxiety, 
33.9% of SSRI use and 68.6% of TCA use occurred 
amongst patients with no recorded history of doctor di- 
agnosis of depression or anxiety (Table 4). 
Logistic regression of depression diagnosis and GDS 
score found a statistically significant association between 
GDS score and depression diagnosis, OR = 1.15, p < 
0.001 (CI = 1.08 - 1.22). Of the 71 patients with a diag- 
nosis of depression, 48 patients (67.6%) scored 5 or 
higher on the GDS, with a kappa statistic of κ = 0.112 (p 
= 0.001) demonstrating poor agreement between a posi- 
tive screen for mild-severe depression and record of a 
clinical diagnosis of depression. Of the 381 patients with 
no diagnosis of depression, 177 (46.5%) scored five or 
more on the GDS. 
Analyses were repeated with a GDS cut-off of 9 or 
more (reflecting moderate-severe depression). Of the 71 
patients with a clinical diagnosis of depression, only 28 
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Table 3. GDS Categorisations for patients with and without depression, compared by antidepressant use at first clinic visit (N = 436). 
No History of Depression 
N = 367 (84.2%) 
History of Depression 
N = 69 (15.8%) 
No Antidepressant 
N = 310 
Antidepressant 
N = 57 
No Antidepressant 
N = 19 
Antidepressant 
N = 50 GDS Categorisation 
















N = 220 172 55.5 86.9 26 45.6 13.1 4 21.1 18.2 18 36.0 81.8
Mild Depression 
N = 125 87 28.1 82.9 18 31.6 17.1 5 26.3 25.0 15 30.0 75.0
Moderate Depression 
N = 54 33 10.6 82.5 7 12.3 17.5 4 21.1 28.6 10 20.0 71.4
Severe Depression 
N = 37 18 5.8 75.0 6 10.5 25.0 6 31.6 46.2 7 14.0 53.8
 
Table 4. History of depression and antidepressant type. 
 No Depression History Depression History 
SSRI 20 (33.9%) 39 (66.1%) 
TCA 24 (68.6%) 11 (31.4%) 
 
patients (39.4%) had a GDS score of 9 or more, with a 
kappa statistic of κ = 0.189 (p < 0.001) demonstrating 
poor agreement between a positive screen for moderate- 
severe depression and a diagnosis of depression. Of the 
381 patients with no clinical diagnosis of depression, 68 
patients (17.8%) scored 9 or more on the GDS. An ROC 
graph (Figure 1) demonstrated poor discriminatory 
power of depression diagnosis for the GDS, AUC = 0.65. 
p < 0.001. A cut-off score of 5 had a sensitivity of 0.68 
and a specificity of 0.47, and a cut-off score of 9 had a 
sensitivity of 0.35 and a specificity of 0.14. 
4. DISCUSSION 
Contrary to expectations, the GDS cut-off of 5 re- 
flected a prevalence of depressive symptoms in this out- 
patient clinic population considerably higher than the 
prevalence of depression diagnosis, which, as hypothe- 
sised, exceeded the community prevalence of depression 
in Australians aged over 65 years of 12.5% [22]. The 
weak association between depression diagnosis and GDS 
categorisation and the poor agreement demonstrated by 
the ROC curve suggests that the two measures are not 
evaluating the same phenomenon. More than fifty per- 
cent of patients diagnosed with depression and taking an 
antidepressant still experienced depressive symptoms, 
suggesting the possibility of under-treatment in this 
group. Although logistic regression found that severity of 
depression as measured by GDS score increased the like- 
lihood of having a diagnosis of depression, supporting 
previous findings from the Hampshire Depression Study 
[23], a large proportion of patients with high GDS scores 
did not have a doctor diagnosis of depression, suggesting 
under-diagnosis in this group. 
 
Figure 1. ROC graph of GDS score and depression diagnosis. 
 
The GDS may demonstrate a genuinely high preva- 
lence of depressive symptoms in the older multimorbid 
demographic, but with a sensitivity of 91% and a speci- 
ficity of 72% for depression [18], a cut-off score of 5 
creates risk of obtaining false positives, which may in- 
crease in a high-risk population. Considering the poor 
agreement between GDS and depression diagnosis dem- 
onstrated by the ROCs, a cut-off value of 5 may over- 
estimate the prevalence of depressive symptoms, render- 
ing it inappropriate for this population. Somatic or be- 
havioural questions may be affected by the complex 
symptom profile generated by multiple physical illnesses. 
Future research should generate ROC graphs using a 
gold standard diagnostic tool to identify the most appro- 
priate GDS cut-off scores for clinical relevance, and 
evaluate individual GDS items for their appropriateness 
in this population. Future research could also evaluate 
whether other parameters, such as frailty or multimorbid- 
ity, predict positive responses to specific questions, with 
a view to proposing different cut-off scores or removing 
questions with poor discriminatory ability when used in  
this population. 
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Clinical relevance should be considered when select- 
ing cut-off scores for depression diagnosis in multimor- 
bid patients. Previous research suggests that whilst GPs 
miss mild cases of depression in the general practice 
population, the likelihood of being diagnosed with de- 
pression increases with severity [23]. Failure to detect 
mild depression may not affect prognosis, as less severe 
depression has been found to resolve without detection 
or intervention in otherwise healthy adults [24]. This 
assurance cannot, however, be generalised to multimor- 
bid patients. In contrast to Thompson et al.’s 2001 find- 
ings, the current study found that sixty-five percent of all 
patients who scored as severely depressed using the GDS 
had not been diagnosed with depression, suggesting that 
severe depression may present differently in older pa- 
tients with multiple chronic conditions. 
Whilst many patients reporting severe depressive 
symptoms have been neither diagnosed with depression 
nor prescribed medication, a large proportion of patients 
without depression diagnosis are taking antidepressants. 
This may in part be attributable to the prescribing of tri- 
cyclic antidepressants (TCAs) for a range of different 
complaints; the prescription of selective serotonin reup- 
take inhibitors (SSRIs) to 33.9% of patients with no his- 
tory of depression, however, raises questions about medi- 
cation practices in this population, as SSRIs are usually 
used only for depression or anxiety. Future exploration of 
antidepressant prescribing practices in the multimorbid 
population would be valuable, particularly as patients with 
severe depressive symptoms remain untreated. 
It is noteworthy that almost one third of patients at- 
tending the clinic were excluded from the present analy- 
ses because they were under 65 years of age (32.5%). 
Whilst validated in older populations, no studies have 
examined the applicability of the GDS to patients under 
65. As no age classification has been applied to the term 
“geriatric” it may be appropriate to consider it a descrip- 
tion of an individual’s health status and physical function, 
and examine the applicability of the GDS in younger 
multimorbid patients. Additionally, with most studies of 
multimorbidity restricted to participants aged 65 and older, 
the large percentage of younger multimorbid patients 
excluded suggests that a substantial proportion of the 
multimorbid population is being overlooked. This sup-
ports previous findings that multimorbidity affects adults 
of all ages [2,25], and suggests that future multimorbid- 
ity research should include younger multimorbid pa- 
tients. 
Limitations 
Depression is not diagnosed at the multidisciplinary 
clinic; consequently, inclusion of a diagnosis of depres- 
sion in the clinic database was reliant on referral letters. 
Neither the recency, nor the source (general practitioner, 
psychiatrist), nor the method (screening questionnaire, 
clinical judgement or interview) of depression diagnosis 
were documented, making differentiation between his- 
torical and current depression, or single depressive epi- 
sodes and chronic recurrent depression, impossible. 
There may be inconsistencies both in diagnostic defini- 
tion and criteria, as the diagnostic label does not capture 
the breadth of depression experience and severity across 
the patient group. Future research exploring the experi- 
ences of depression diagnosis amongst multimorbid pa- 
tients is necessary to shed light on the diagnostic process 
in this population. 
5. CONCLUSION 
This study revealed that depressive symptoms may not 
be recognised in this population, as although nearly half 
of patients with multiple chronic conditions treated at a 
multi-disciplinary outpatient clinic screened positive for 
depressive symptoms using the Geriatric Depression 
Scale (GDS), the rate of doctor-diagnosed depression 
was only slightly higher than the community average. 
The poor agreement between depression diagnosis and 
symptom severity suggests a high level of undiagnosed 
depression in this population, and inconsistent associa- 
tion of depression diagnosis with antidepressant pre- 
scription raises questions about prescription practices 
amongst multimorbid patients. Future research is needed 
to clarify the true prevalence of depressive symptoms in 
this complex and vulnerable population and barriers to 
screening and diagnosis in primary care. 
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